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The aim of this study was to investigate associations between serum concentrations of brominated ﬂame
retardants and personal characteristics, including diet, in adults participating in a population-based
study in Sweden 2010e11. Moreover, observed concentrations were used in a health risk assessment,
using published health-based reference values. Serum samples of 170 adult individuals of both sexes
were analyzed for 10 PBDE congeners and HBCD by GC-MS. When including concentrations between LOD
and LOQ, highest median serum concentration was observed for BDE-153 (1.2 ng/g serum lipid), followed
by BDE-209 (0.95 ng/g lipid), BDE-47 (0.49 ng/g lipid) and BDE-100 (0.21 ng/g lipid). Median concen-
tration of HBCD was 0.10 ng/g lipid. A few markedly elevated concentrations of BDE-209, HBCD (77
e78 ng/g lipid) and BDE-47 (44 ng/g lipid) were observed. The only statistical signiﬁcant ﬁndings were
higher BDE-153 concentrations in men than in women, and positive associations between serum BDE-
153 concentrations and consumption of ﬁsh (total), beef, mutton and poultry. PBDE concentrations
were in accordance with concentrations reported in other European countries but generally lower than
those found in North America. Median PBDE serum concentrations observed in adults from Sweden
suggest sufﬁcient health protection, when compared with published health-based reference values,
although some outliers with high serum concentrations had lower safety margins.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Brominated ﬂame retardants (BFRs) have for a long time been
used to decrease ﬂammability of a variety of products in houses and
homes, for instance electronic devices, electric cables and homeLtd. This is an open access article utextiles. An unwanted side effect of BFR use is environmental BFR
pollution and human BFR exposure (de Wit, 2002; Darnerud et al.,
2001). In experimental animals BFRs adversely affect liver and
thyroid function, and causes developmental neurotoxicity
(Darnerud, 2003; Birnbaum and Staskal, 2004; Legler, 2008).
Neurodevelopment was used as a critical endpoint in the human
health risk assessment of the BFRs polybrominated diphenyl ethers
(PBDEs) in food performed by the European Food Safety Authoritynder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
H. Bjermo et al. / Chemosphere 167 (2017) 485e491486(EFSA) in 2011 (EFSA, 2011). However, food is not the only source for
BFR exposure. For small children a large part of the total BFR
exposuremay come from ingestion of indoor dust (e.g. Harrad et al.,
2010). An increasing number of epidemiological studies show as-
sociations between exposure to BFRs and adverse health effects,
such as thyroid function disturbances, diabetes, and neuro-
behavioral and developmental disorders (Kim et al., 2014),
although causality of associations have not been ﬁrmly established.
Human exposure to most of the studied PBDE increased up to the
end of the 1990s in Sweden but has thereafter decreased
(F€angstr€om et al., 2008; Lignell et al., 2009).
The Swedish National Food Agency (NFA) recurrently performs
population-based food consumption surveys and in the most
recent food survey (Riksmaten 2010e11, adults) BFRs were bio-
monitored in a subsample of the participants. The aim of the pre-
sent study is to determine serum concentrations of BFRs in a
representative sample of the adult Swedish population, and to
investigate possible associations with diet or life style factors.
Observed concentrations were used in a health risk assessment,
using health-based reference values published by EFSA (EFSA,
2011).
2. Materials and methods
2.1. Study design and population
Riksmaten 2010e11 is a Swedish national survey investigating
dietary habits. The study was conducted between May 2010 and
July 2011. The biomonitoring study was based on a subgroup of
individuals donating blood samples. The subjects in the subgroup
were randomly selected from the Swedish population registry,
taking season and where the blood and urine collectionwould take
place into account, but independent of the main study population.
The blood sampling was performed at the Swedish Occupational
and Environmental Medicine Centers (OEMCs). Based on the OEMC
service areas, Sweden were divided into seven regions. From each
region, the region capital (Link€oping, Lund, Stockholm, Umeå,
Uppsala, Gothenburg, €Orebro) and two random additional counties
were selected. Data were collected at four occasions (i.e. May/June
2010, August/September 2010, January/February 2011, and April/
May 2011). An equal number of individuals were selected in each
region independent of population size. Altogether, 1008 individuals
between 18 and 80 years old were randomly selected and invited to
participate in the blood sampling (12 individuals per county and
occasion) by letter. The invitation was followed-up with a tele-
phone call. Those accepting to participate were given further in-
structions on how to record their diet (see below) by additional
phone calls. The relevant OEMC also contacted the participant for
an appointment to draw blood and urine. Of the 300 individuals
who choose to participate (30%), blood samples from 170 in-
dividuals were analyzed for BFR concentrations. The other 130
participants were excluded due to small serum volumes. Further
exclusion of 24 participants due to incomplete food record and/or
questionnaire data left 146 individuals in the sample population in
which associations were studied. All participants gave oral
informed consent before entering the study. The study was
approved by the regional ethical committee in Uppsala.
2.2. Assessment of diet and lifestyle
Food consumption was registered by the participants using a
web-based food record. The registrationwas performed during four
consecutive days and the starting day for each participant was
randomly selected (Tuesday, Wednesday, Saturday or Sunday) to
cover all days of the week. Portion size was estimated by theparticipants using a portion guidewith photographs. Additionally, a
food frequency questionnaire was used to assess consumption of
less frequently consumed food items (e.g. ﬁsh, meat). Information
about physical activity and breastfeeding were collected by a
questionnaire. Highest completed education was assessed using
Swedish register data and participants were divided into three
groups of education, having completed elementary school, high-
school, or university education. Breastfeeding by women was
categorized as not having breastfed, having breastfed for totally
1e6 months, 7e12 months, or more than 12 months. Weight and
height were reported by the participants and body mass index
(BMI) was calculated as weight [kg] divided by height [m] squared.
2.3. Sampling of serum
Non-fasting serum was sampled at the OEMC in each region or
by district health care centers. Blood was drawn from an ante-
cubital vein. Serum was separated and stored at 20 C until
analysis. Four ml serum was used for the BFR analyses.
2.4. BFR analyses
The analytical method used for determination of brominated
ﬂame retardants in human blood serum has been described earlier
(Darnerud et al., 2015). Brieﬂy, serumwas extracted with methanol
and a diethyl ether/n-hexane mixture. The organic phase was
washed twice with aqueous potassium chloride and transferred to
a pre-weighed test tube. The lipid weight was determined gravi-
metrically. In order to remove lipids and other polar materials the
lipid extract was re-dissolved in n-hexane and treated with
concentrated sulfuric acid and subsequently transferred to an
impregnated silica/sulfuric acid gel column and eluted with a
mixture of dichloromethane/n-hexane. The lipid-free extract was
transferred to a pre-washed silica gel column and eluted with n-
hexane (fraction 1) and dichloromethane/n-hexane (fraction 2).
The second fraction was kept in an amber GC vial until analysis.
Quantiﬁcation of the analytes (BDE-28, -47, -66, -99, -100, -138,
-153, -154, -183, -209 and HBCD) was performed by GC/MS/ECNI-
SIM (Agilent 6890 N GC/Agilent 5973 N MS). Six ml (2  3 ml) was
injected in pulsed splitless mode using a programmable tempera-
ture vaporizing (PTV) injector. The analytes were separated on a
DB-5MS column (J&W Scientiﬁc) and the oven temperature was
programmed from 60 C to 325 C. The different analytes were
identiﬁed by their retention times relative to the internal standards
(BDE-85 and 13C-BDE-209). The GC and MS operating conditions
are described in more detail elsewhere (Darnerud et al., 2015). The
samples were quantiﬁed using calibration curves created from the
calibration standards analyzed in the same run. Quadratic regres-
sion with the inverse square of concentration was used for the
calibration curves. Since the analytical method do not separate
brominated biphenyl 153 (BB-153) and BDE-154, the concentration
of BDE-154 is reported as a sum of BDE-154 and BB-153.
2.5. Quality assurance
The glassware used was either heated in an oven or rinsed with
acetone before use and all solvents were tested for trace amounts of
analytes. A chemical blank and a spiked in-house control sample
were included in each extraction series to monitor background
levels and the methods accuracy. For each batch of samples, the
corresponding blank sample levels were subtracted from the
sample levels. The limit of detection (LOD) was determined as three
times the standard deviation of the blanks analyzed together with
the samples and the limit of quantiﬁcation (LOQ) was determined












Fig. 1. Cluster analysis of the studied BDE congeners and HBCD.
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value of this twowas selected as LOQ. The LOQ varied between 0.25
and 1.9 ng/g lipid weight. The expanded uncertainty in the mea-
surements was 20e40% (calculated using a coverage factor of 2
which gives a level of conﬁdence of approximately 95%). Levels
between LOD and LOQ were reported in order to improve the po-
wer of statistical analyses, although such data are less accuratewith
a higher probable uncertainty.
2.6. Statistical analyses
Clustering of the BDE congeners was investigated by average
linkage cluster analysis. The cluster analysis gives information on
the degree of similarity in occurrence of the studied congeners in
the study group, suggesting similar exposure sources. In statistical
analyses results of cluster analyses may be used to group data for
congeners clustering together. Distributions of the variables were
investigated by Shapiro Wilk test. BDE-154/-brominated biphenyl
(BB)-153, BDE-153 and BDE-183 were normally distributed after
logarithmically transformation whereas all other BDEs were not.
Non-parametric tests were used when investigating the associa-
tions between serum BDE concentrations and personal character-
istics of the participants due to the non-linearity of most
associations. Furthermore, non-parametric tests are less sensitive
for interference of extreme values, which is common for some of
the studied BFRs. Continuous variables were correlated with BDE
concentrations by Spearman's correlation. The relationship be-
tween BDE and categorical variables were examined using Wil-
coxon rank sum test or Kruskal-Wallis test. Associations found to be
signiﬁcant in univariate analyses were further investigated by
adjusting for potential confounders, i.e. age, sex, BMI and educa-
tion. These personal characteristics have earlier been found to be
signiﬁcantly associated with serum concentrations of chemically
related POPs (PCBs and chloropesticides) in the same study group
(Bjermo et al., 2013). The residual method was used in these
adjustedmodels (Willett and Stampfer, 1986). Continuous variables
were categorized into quintiles when using the residual method.
Means of BDE-153 adjusted for age, sex, education and BMI were
calculated by linear models. The statistical analyses were per-
formed using the software package STATA version 11 (STATA cor-
poration). P < 0.05 was considered statistically signiﬁcant.
When the serum concentrations were between LOD and LOQ,
the actual registered concentrations from the analysis were used in
the statistical analysis to improve the statistical power. Levels
below LOD were assigned the value ½LOD. Even if analytically
registered values below LOQ are less accurate than levels above
LOQ, the present procedure will probably result in less bias
compared to replacement of concentrations below LOQ with zero
or ½LOQ (as the two latter will introduce a systematic error) (RSC,
2001; Bergstrand and Karlsson, 2009). In an earlier publication we
have discussed the problems and beneﬁts of the use of registered
concentrations below LOQ in analyses of BFR in serum (Darnerud
et al., 2015). In the present study, statistical analyses of associa-
tions between BFR concentrations and personal characteristics
were limited to BFR congeners for which more than 60% of the
values were above LOQ, i.e. BDE-153 and BDE-209. For the
remaining BDE congeners, and HBCD, statistical analyses would
mainly be based on concentrations below LOQ, making the results
uncertain.
Average linkage cluster analysis was performed on the serum
BFR concentration data (Fig.1). Intermediately brominated (3e5 Br)
BDE congeners showed relatively close relationship, whereas the
hexabrominated BDE-153 as well as both the full-brominated BDE-
209 and HBCD were well separated from each other, and from the
3e5 bromo-DEs. Based on these ﬁndings, we decided to treat theBDE congeners BDE-153 and BDE-209 separately and not to group




Table 1 presents population characteristics of the 170 partici-
pants in comparison with the whole Riksmaten biomonitoring
group (n ¼ 300), and with the adult Swedish population (at year
2010). Therewere nomarked differences in characteristics between
the two former groups. However, the study group had a higher
proportion of individuals with a completed university education
than the general Swedish population (Table 1).
3.2. Serum concentrations of BFRs
Concentrations of PBDE congeners and HBCD are given in
Table 2. The BDE congeners with the highest median levels were
BDE-153 (1.2 ng/g serum lipid), followed by BDE-209 (0.95 ng/g
lipid), BDE-47 (0.49 ng/g lipid) and BDE-100 (0.21 ng/g lipid). The
median concentration of HBCD was 0.10 ng/g lipid. The median
concentration of mixed BDE-154/BB-153 was estimated to 0.28 ng/
g lipid, but with no possibility to separate the relative contribution
of the two congeners. Notably, a few markedly elevated levels were
observed for BDE-209, HBCD (both 77e78 ng/g lipid) and BDE-47
(44 ng/g lipid). All BDE congeners, except BDE-153 and BDE-209,
had a substantial amount of concentrations below LOQ (76e99%)
and were therefore excluded from further statistical analyses (see
Materials and methods, Statistical analysis). BDE-154 was excluded
due to the above mentioned chemical-analytical considerations.
3.3. Associations with personal characteristics
Serum concentrations of BDE-153 were higher among men than
among women (median [Q1eQ3]: 1.6 [1.2e2.1] vs. 1.0 [0.8e1.3] ng/
kg lipid), also after adjustment for age, education and BMI. No sex
differences were observed for BDE-209 (0.9 [0.7e1.8] for men, 1.0
[0.7e1.6] for women). Among women, BDE-153 and BDE-209
concentrations did not differ depending on breast feeding time,
and BDE-153was still associatedwith sex after breast feeding of the
women was taken into account. BDE-153 and BDE-209 concentra-
tions were not correlated with age and BMI (BDE-153: r ¼ 0.09,
Table 1
Basic data on recruited individuals in the Riksmaten biomonitoring subgroup with BFR data (N ¼ 170).
Parameter Unit Riksmaten biomonitoring subgroupa (N ¼ 170) Riksmaten biomonitoring population (N ¼ 300) Swedish populationb
Age (yr) mean ± SD 50 ± 17 50 ± 17 e
Women (%) percent (N) 53% (90) 52% (157) 50%
BMI (kg/m2) median (quartiles 1e3) 25 (23e28) 25 (23e27)c e
Highest completed education
Elementary school percent (N) 9% (15) 12% (35) 22%
High school percent (N) 46% (79) 45% (135) 45%
University percent (N) 45% (76) 43% (130) 33%
a Study population.
b National data for the Swedish adult population (age 20e79 years) at year 2010 (Statistics Sweden, 2016) when Riksmaten was conducted.
c N ¼ 279.
Table 2
Serum concentrations of BDE congeners (in ng/g lipid wt.) in a subsample of Riksmaten 2010e11 (N ¼ 170).
Congener LODa ng/g lw N (%) >LOD LOQa ng/g lw N (%) >LOQb Medianc 95th c perc. Max
BDE-28 0.055 78(46) 0.25 8 (5) 0.028 0.23 2.4
BDE-47 0.36 103 (61) 1.20 41 (24) 0.49 3.4 44
BDE-66 0.044 4 (2) 0.25 1 (0.6) 0.022 0.022 0.30
BDE-99 0.58 24 (14) 1.90 5 (3) 0.29 1.3 6.1
BDE-100 0.13 117 (69) 0.40 37 (22) 0.21 0.93 3.7
BDE-153 0.017 170 (100) 0.25 170 (100) 1.2 3.4 7.0
(BDE-154)d 0.044 169 (99) 0.25 99 (58) 0.28 0.92 5.4
BDE-138 0.016 6 (4) 0.25 1 (0.6) 0.008 0.008 0.67
BDE-183 0.017 167 (98) 0.25 5 (3) 0.066 0.21 0.76
BDE-209 0.20 167 (98) 0.70 125 (74) 0.95 4.5 78
HBCD 0.017 103 (63) 0.50 22 (13) 0.10 1.8 77
a LOD, limit of detection; LOQ, limit of quantiﬁcation.
b Further statistical analyses of associations were performed only on congeners with at least 60% of values above LOQ (i.e. on BDE-153 and BDE-207).
c Median and 95thpercentile values (conc. <LOD ¼ ½LOD) were not used for data sets with less than 60% above LOD (shaded).
d BDE-154 and BB-153 could not be separated in the chemical analysis.
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r ¼ 0.06, p ¼ 0.41).
In univariate analyses serum BDE-153 and BDE-209 concentra-
tions were not related to consumption of different types of foods
(results not shown), except in the cases of BDE-153 and ﬁsh and
meats (Fig. 2). BDE-153 was positively associated with total ﬁsh
consumption, including shellﬁsh, when assessed by 4-days food
records (r¼ 0.15, p¼ 0.04), but not when assessed by the frequency
questionnaire (p ¼ 0.11). BDE-153 concentrations were positively
related with consumption of fatty ﬁsh (food frequency question-
naire) whereas no relationships were observed for lean ﬁsh
(r ¼ 0.16, p ¼ 0.04; r ¼ 0.12 and p ¼ 0.13). Fig. 2a presents the as-
sociation between BDE-153 levels and fatty ﬁsh intake (categorized
as consumption less than once per month, at least once per month
but less than once per week, and at least once per week). Associ-
ations between BDE-153 and ﬁsh consumptionwere not signiﬁcant
after adjustments for age, sex, education and BMI.
BDE-153 concentrations were positively associated with con-
sumption of beef, mutton and poultry assessed by the food fre-
quency questionnaire (Fig. 2bed). The associations with
consumption of mutton and fowl were signiﬁcant also after
adjustment for age, sex, education and BMI.
4. Discussion
4.1. Serum concentrations of BFRs
The results of our population-based biomonitoring study of
BFRs in adults from Swedish show that themedian concentration of
BDE-153 was highest, followed by BDE-209, BDE-47 and BDE-100.
During the most recent years these four congeners have generally
been reported to be present at highest concentrations among BFRs
in human blood samples from general populations in Europe, NorthAmerica, Asia and Oceanias (Frederiksen et al., 2009). Particularly in
North America, BDE-47 concentrations in blood have been found
especially high, and this BDE congener has been the main driver for
the high North American PBDE levels as compared to other regions,
including Europe (Fromme et al., 2016). The review by Frederiksen
et al. (2009), including data from 1977 to 2006, in most cases re-
ported higher concentrations of BDE-47 relative to BDE-153 also
from regions other than North America. This is in line with results
of earlier Swedish studies of non-occupationally exposed women
(Sj€odin et al., 1999; Guvenius et al., 2003; sampled 1997 and
2000e01, respectively). In a more recent Swedish study from 2010,
a group of men and women (N ¼ 31) with expected background
PBDE exposure, had similar BDE-47 and BDE-153 serum concen-
trations (both around 1 ng/g lipid) (Strid et al., 2014). In the present
study, representing adults in Sweden in 2010-11, concentrations of
BDE-153 were even higher than BDE-47 concentrations. This
gradual shift is most likely a consequence of a recent temporal
decrease in BDE-47 and an increase, or steady state, in BDE-153
concentrations in adults from Sweden (discussed by Darnerud
et al., 2015).
The median BDE-209 concentration was the second highest
among the BDE congeners analyzed in our population-based study
of Swedish adults. The previously reported concentrations of BDE-
209 vary substantially between studies, which in part could be due
to analytical problems (e.g. Stapleton, 2006). As shown by Fromme
et al. (2016), the serum levels of BDE-209 are not signiﬁcantly
higher in the North America compared to other regions. Among
young nursing women from Sweden (Darnerud et al., 2015) the
average serum concentrations of the four main BDE congeners
(BDE-47, -100, -153, -209) were lower (60e94%) than among the
Swedish adults of both sexes in the present study. The lower BDE
concentrations in the young nursing women could reﬂect
pregnancy/nursing-related changes in physiological and kinetic
Fig. 2. Association between intake of fatty ﬁsh, beef, mutton and fowl meat and serum levels of BDE-153 (ng/kg lipid) (based on food frequency questionnaire). Data are presented
as means (95% CI) adjusted for age, sex, education, and BMI. Unadjusted p-values were calculated by Kruskal-Wallis test and adjusted p-values were calculated by residual method.
(Fatty ﬁsh: N(<1/month) ¼ 22, N(1/month) ¼ 61, N(1/week) ¼ 87; Beef: N(<1/month) ¼ 26, N(1/month) ¼ 50, N(1/week) ¼ 90; Mutton: N(never) ¼ 57, N(<1/month) ¼ 92,
N(1/month) ¼ 16; Fowl: N(<1/month) ¼ 13, N(1/month) ¼ 49, N(1/week) ¼ 104).
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lipid-soluble POPs (Glynn et al., 2011). For instance, the increase in
lipid content of the blood during pregnancy could result in a
“dilution effect” on serum lipid PBDE concentrations and this effect
could persist at least during the early part of the nursing period. In
addition, excretion of PBDEs via breast milk may contribute to the
lower serum lipid PBDE concentrations in young nursing women
(e.g. Sahlstr€om et al., 2014). In our study serum lipid BDE-153
concentrations among women were not associated with breast-
feeding time. A possible explanation could be that there was a
relatively long time-span between the periods of nursing and the
blood sampling of the participating women in our study. Moreover,
a limited number of study participants may have weakened the
statistical power for detecting an association between BDE-153
serum concentrations in the women and breast-feeding time.4.2. Associations with personal characteristics
It is well known from several studies that ﬁsh and ﬁsh products
are major dietary sources of PBDEs in Sweden (e.g. T€ornkvist et al.,
2011). We found a weak positive association between serum con-
centrations of BDE-153 and ﬁsh consumption, as registered by food
records. However, the association dissipated after adjustment for
covariates (i.e. age, sex, education and BMI), showing that other
personal characteristics than ﬁsh consumption explain the major
part of the variation in BDE-153 concentrations observed by us. We
observed positive associations between BDE-153 concentrations
and consumption of beef, mutton and fowl meat. The presence of
PBDEs in meat and meat products has been reported from both
Europe and North America (Bocio et al., 2003 (Spain); Schecter
et al., 2006, 2010; Huwe and West, 2011 (USA); T€ornkvist et al.,
2011 (Sweden)). In the most recent Swedish market basket study,
consumption of meat and meat products were estimated tocontribute on average 24% of the total BDE-153 intake from food
(NFA, 2012).
Certain study participants had much higher BDE serum con-
centrations than the other participants. For both BDE-153 and BDE-
209 the maximum measured concentrations were approximately
100 times higher than the median concentrations. This shows that
certain individuals have a high PBDE exposure from unknown
sources.4.3. Risk assessment
In the EFSA Scientiﬁc Opinion from 2011, effects on neuro-
development were identiﬁed as the critical endpoint for PBDEs in
the health risk assessment (EFSA, 2011). By using estimated body
burden (BB) data obtained in our study, comparisons could bemade
with the BB data at BMDL10 from animal studies reported by EFSA.
From these comparisons BB margin of exposures (BB MOE) were
determined. The individual BFR BB in our studywas estimated from
the measured serum lipid concentrations of BFRs and the body
weight of each participant, assuming 20% body fat. The comparison
(Table 3) showed that BB MOEs based onmedian serum levels were
large, above 250, in case of BDE-47 and BDE-153, and therefore of
no apparent health concern as deﬁned by EFSA (EFSA, 2011).
Maximum serum concentrations resulted in much lower MOEs and
thus also lower safety margins. Based on EU dietary BFR intake
data, EFSA expressed concern about BDE-99. Notably, BDE-99
showed the lowest MOE in our assessment (MOE ¼ 7.5) when us-
ing maximum serum concentrations. According to EFSA any MOE
larger than 2.5 indicates that health concerns are unlikely to
happen. The general temporal trends for PBDEs in Swedish human
samples are showing decreasing concentrations, except for higher
brominated PBDEs (Darnerud et al., 2015), which imply that the
MOEs for BDE-99 will likely increase in the future.
Table 3
Risk assessment of BDE-47, BDE-99 and BDE-153, based on calculated body burdens from serum levels analyzed in the present paper. Margins of exposure are produced with
reference to the EFSA risk assessment on PBDEs (EFSA, 2011).
Congener a Median/max. Serum level b Calc. body burden (BB) c,d BB BMDL10 (EFSA data) c MOE (BB BMDL10/BB)
BDE-47 Median 0.49 0.098 232 2367
Maximum 44 8.8 232 26
BDE-99 Maximume 6.1 1.2 9 7.5
BDE-153 Median 1.2 0.24 62 258
Maximum 7.0 1.4 62 44
a BDE-209 not included due to lack of BB BMDL10 data.
b In ng/g lipid.
c In mg/kg body wt.
d Body burden values were achieved by assuming 20% body fat (fat adjusted serum levels  0.2).
e Only maximum level of BDE-99 due to few levels above LOD, making median level uncertain.
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BDE-153 was the only congener with all serum samples having
concentrations above LOQ. BDE-153was also the congener showing
associations with consumption of food. For the other BFRs, con-
centrations were in most cases too uncertain to allow for statistical
analyses of associations with personal characteristics. Another
limitation was the relative low number of analyzed samples,
compromising the statistical power to detect associations between
BFR concentrations and personal characteristics. The study also had
a low participation rate, which may have inﬂuenced the repre-
sentativeness of results. However, as shown in Table 1, the study
population with BFR data was representative for the whole Riks-
maten biomonitoring populationwith regard to age, sex, education
and BMI. When compared with national data of the Swedish pop-
ulation, slightly more women and more highly educated subjects
participated in the present study. In spite of these small differences,
we believe that our data is generalizable to the Swedish adult
population. Strength of the study is the nationwide sampling
covering both men and women aged 18e80 years. Also, the
comprehensive dietary and life-style questionnaire gave an op-
portunity to study associations between BFR concentrations and
personal characteristics. Even so, limitations in length of ques-
tionnaire may result in lack of potentially interesting data.5. Conclusions
In this Swedish population-based study median serum lipid
concentrations of BDE-153 and BDE-209 were highest among the
studied BFRs. The variation of serum concentrations were high and
for BDE-47 and BDE-209 the maximum/median concentration
quotient was around 100. The serum concentrations in this popu-
lation with background BFR exposures are generally in accordance
with those reported from other European countries, but generally
lower than levels found in USA. A few associations were found
between BDE-153 and meat consumption, but no signiﬁcant asso-
ciations with other personal characteristics were found. Based on
our results, current BFR body burdens among adults give sufﬁcient
MOEs in relation to body burdens causing negative effects in
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